Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
05/2014
05/27/2014US8735382 Infusion and injection solution of levodopa
05/27/2014US8735350 Reversible pegylated drugs
05/27/2014US8734850 Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
05/27/2014US8734770 Methods and compositions for administration of TRPV1 agonists
05/27/2014CA2529584C Jucara and acai fruit-based dietary supplements
05/27/2014CA2497552C Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
05/22/2014US20140141429 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
05/22/2014US20140141073 Anti-virus hydrophilic polymeric material
05/22/2014US20140141017 Methods of diagnosing atherosclerosis by measuring apoci
05/21/2014CN101675992B β-淀粉样蛋白-类似物-T-细胞表位疫苗 β- amyloid - like -T- cell epitope vaccine
05/20/2014CA2519023C Facially amphiphilic polymers and oligomers and uses thereof
05/15/2014US20140135387 Use of equol of treating androgen mediated diseases
05/15/2014US20140134753 Methods for treating transthyretin amyloid diseases
05/14/2014CN1968685B 互动药物的筛选 Drug interaction screening
05/14/2014CN101327196B 剂型和施药方法 Formulations and application methods
05/08/2014US20140128590 Hydrolases, nucleic acids encoding them and methods for making and using them
05/07/2014CN1845750B 用于预防及治疗认知衰退和年龄相关的记忆障碍的无取代b环类黄酮和黄烷混合物的组合物 For the prevention and treatment of age-related cognitive decline and memory impairment in non-substituted b-Ring flavonoids and flavan mixture composition
05/06/2014CA2511838C Uses of mammalian cytokine; related reagents
05/01/2014US20140121365 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/01/2014US20140121364 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/01/2014US20140121352 Reversible pegylated drugs
05/01/2014US20140120085 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
04/2014
04/30/2014EP2725008A1 N,N-dihalogenated amino acids and derivatives
04/30/2014CN103751211A Methods and pharmaceutical compositions for healing wounds
04/30/2014CN101843897B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
04/30/2014CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/29/2014US8709998 Peptide vectors
04/29/2014US8709478 Once daily formulations of tetracyclines
04/29/2014US8709405 Cancer vaccines containing epitopes of oncofetal antigen
04/29/2014US8709342 Antimicrobial flush solutions
04/29/2014CA2516078C Catechol compositions and use thereof
04/29/2014CA2507023C Functional fragrance precursor
04/24/2014US20140112980 Abuse-resistant pharmaceutical compositions
04/22/2014US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/22/2014US8703212 Base material for pharmaceutical and/or cosmetic cream (herbal composition for itchy or infected skin)
04/22/2014US8703186 Abuse-resistant oral dosage forms and method of use thereof
04/22/2014US8703053 Antiseptic compositions, methods and systems
04/22/2014CA2534897C Process of making flowable hemostatic compositions and devices containing such compositions
04/17/2014US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof
04/17/2014US20140107067 Compositions comprising dietary fat complexers and methods for their use
04/17/2014US20140107058 Pharmaceutical compositions comprising forms of 5-azacytidine
04/17/2014US20140105895 Treatment of solid tumors with rapamycin derivatives
04/16/2014EP2719394A1 Peptides antibodies directed thereagainst for diagnosing and treating amyloid-associated diseases
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697663 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
04/15/2014US8697634 Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
04/15/2014US8697151 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
04/15/2014US8697047 Stable immunogenic product comprising antigenic heterocomplexes
04/10/2014US20140100258 Methods for treating degenerative diseases/injuries
04/10/2014US20140099716 Monoclonal antibody capable of binding integrin alpha 10 beta 1
04/10/2014US20140099339 Vaccine against streptococcus pneumoniae
04/08/2014US8691837 Substituted imidazo ring systems and methods
04/08/2014US8691776 Synthesis of high molecular weight iron-saccharidic complexes
04/08/2014US8691234 Vaccine formulation potentiated by the combination of DNA and an antigen
04/08/2014CA2540703C Methods and compositions for mycoplasma pneumoniae exotoxins
04/03/2014US20140094435 Use of Dextran Sulfate
04/03/2014US20140093484 Use of Dextran Sulfate
04/03/2014US20140093476 Methods for treating pain
04/01/2014US8685374 EDTA containing compositions and uses thereof
04/01/2014CA2515444C Immunoglobulin formulation and method of preparation thereof
03/2014
03/25/2014US8680114 AKT protein kinase inhibitors
03/25/2014US8679465 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent
03/25/2014US8679078 Ocular drug delivery device
03/25/2014CA2547020C 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
03/19/2014CN102697737B Tumor-targeting drug-loaded particles
03/18/2014US8673932 Oxime substituted imidazo-containing compounds
03/18/2014US8673632 Modulation of apolipoprotein (a) expression
03/18/2014US8673552 Druggable regions in the dengue virus envelope glycoprotein and methods of using the same
03/18/2014US8673350 Pharmaceutical formulations
03/18/2014CA2520671C Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
03/13/2014US20140072626 Once daily formulations of tetracyclines
03/12/2014CN103623408A Low dose methods for treating disorders in which tnf dollar g(a) activity is detrimental
03/12/2014CN101418044B Immunoglobulin variants and uses thereof
03/11/2014US8668932 Extended release venlafaxine formulation
03/06/2014US20140065081 Functional fragrance precursor
03/06/2014US20140065063 Therapeutic use of anti-cs1 antibodies
03/04/2014US8663203 Robotic arms DLUs for performing surgical tasks
02/2014
02/27/2014US20140058063 Vitamin receptor binding drug delivery conjugates
02/27/2014US20140057963 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
02/27/2014US20140057923 Treating Sexual Desire Disorders with Flibanserin
02/27/2014US20140056826 Functional fragrance precursor
02/27/2014US20140056825 Functional fragrance precursor
02/27/2014DE60000133C5 Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen Essential fatty acids for the prevention of cardiovascular attacks
02/26/2014CN1886117B Pharmaceutical compositions
02/25/2014US8658212 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
02/19/2014CN103585136A Methods and compositions for delivery of catecholic butanes for treatment of tumors
02/18/2014US8653119 Methods for treating transthyretin amyloid diseases
02/18/2014CA2677430C Compositions comprising dietary fat complexer and methods for their use
02/18/2014CA2538840C Dna vaccine compositions and methods of use
02/18/2014CA2507898C Immunoglobulin variants and uses thereof
02/11/2014CA2529496C Anti-cd74 immunoconjugates and methods
02/11/2014CA2521655C Abuse-resistant oral dosage forms and method of use thereof
02/11/2014CA2499214C Stable immunogenic product comprising antigenic heterocomplexes
02/11/2014CA2498502C Recombinant clostridial toxin fragments with proteolytic activation
02/06/2014US20140039046 Compositions and products containing s-equol, and methods for their making
02/05/2014CN103554261A A CA6 antigen-specific cytotoxic conjugate and methods of using the same
02/04/2014US8642760 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
02/04/2014CA2548180C Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
02/04/2014CA2543484C Modulation of immune response to an immunogen with ctla-4 and tnfbp
02/04/2014CA2498008C Novel composition and methods for the treatment of immune related diseases
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 295